Medicaid work requirements interim rule restricts medical frailty exemptions
CMS issued an interim final rule on Medicaid work requirements adopting a restrictive definition of medical frailty, differing from states' expectations.
Objective Facts
On June 1, 2026, CMS issued an interim final rule on Medicaid work requirements adopting a restrictive definition of medical frailty. The 2025 reconciliation law requires 43 states to condition Medicaid eligibility for adults in the ACA Medicaid expansion group on meeting work requirements starting January 1, 2027. The rule ties medical frailty specifically to the ability to comply with the community engagement requirement and prohibits states from adding categories of individuals to the medical frailty definition. The rule does not allow states to exempt all people with cancer, HIV, Parkinson's disease, or multiple sclerosis. The rule departs significantly from what CMS had been telling states, and appears inconsistent with H.R. 1, with litigation likely.
Left-Leaning Perspective
Left-leaning outlets emphasized the gap between the rule and the law's original intent. The Center on Budget and Policy Priorities, a nonpartisan but progressive research organization, released a detailed analysis arguing that the rule adds a requirement not in H.R. 1, mandating that medical frailty be limited to situations where an individual's condition impairs their ability to meet the work requirement, when the statute itself lists qualifying conditions without this functional impairment test. Senior fellow Allison Orris explained that it will no longer be enough for somebody to have cancer—they will have to raise their hand or the state will have to determine that not only do they have a cancer diagnosis, but that their cancer diagnosis is serious enough to show significant inability to comply. Patient advocacy groups uniformly opposed the rule. The American Cancer Society Cancer Action Network, through president Lisa Lacasse, warned that the exemption process will overwhelm state Medicaid offices and the CMS is piling on additional documentation and logistical challenges for individuals who need to enroll or maintain coverage. The HIV+Hepatitis Policy Institute's Carl Schmid stated that this added requirement was not in the law and puts the health of people living with HIV and viral hepatitis at risk. Left-leaning coverage stressed the rule's departure from previous CMS guidance and its likely illegality. CBPP noted the rule departs significantly from what CMS had been telling states for months, appears inconsistent with H.R. 1's plain language, and litigation is likely. Gwen Nichols of Blood Cancer United, writing in STAT News, declared that the rule is catastrophic for cancer patients and forces states to go far beyond what Congress included, because both Arkansas and Georgia implemented Medicaid work requirements during the first Trump administration and serve as cautionary tales. Progressive outlets and advocates focused on the administrative burden and coverage loss implications. Left-leaning coverage largely omitted Republican arguments about program integrity or fraud concerns. While outlets reported that the Trump administration and Brian Blase praised the rule, progressive coverage did not deeply explore or grapple with the fraud prevention rationale or cite evidence supporting or refuting such concerns. Additionally, left-leaning sources gave limited attention to CMS's statement on functional limitations or to any recognition that diagnosis alone may be insufficient for determining work capacity.
Right-Leaning Perspective
Right-leaning and conservative health policy voices focused on program integrity and fraud prevention. Brian Blase of the Paragon Health Institute, a health policy research group with strong ties to the Trump administration, applauded the rule for ensuring that applicants claiming health problems really have them, stating that 'to succeed, these requirements must be effectively designed and enforced to minimize gaming and abuse,' and adding that he believes the rule 'strikes the appropriate balance between necessary program integrity protections and accommodations for those who genuinely need assistance.' CMS Administrator Dr. Mehmet Oz emphasized the administration's approach. Oz linked the provisions to maintaining program integrity, telling reporters that 'the mantra that we kept coming back to was that we're forgiving but we're not foolish' while noting that the work mandate will preserve Medicaid for the vulnerable. Conservative defenders also invoked historical precedent for work requirements. Oz argued that the work requirements are a page from Democrats' handbook, pointing to when former President Clinton signed into law work requirements for enrollees in Temporary Assistance for Needy Families, saying 'we need to get people to try to work. It's a path to prosperity.' Conservative outlets and officials presented the stricter definition as necessary safeguarding against misuse. Brian Blase of Paragon Health Institute had urged the administration to prohibit self-attestation, pointing to how fraud skyrocketed in the Affordable Care Act marketplaces after the Biden administration paused verification rules during the COVID-19 pandemic. The Trump administration's broader messaging portrayed the rule as compassionate but firm. The Trump administration and its allies defended the work requirements as a way to improve program integrity and encourage employment, with Congressional Republicans describing the provisions during legislative debate as an effort to reduce 'waste, fraud and abuse' within Medicaid and the administration highlighting concerns about fraud in public benefit programs more broadly. Right-leaning coverage gave less weight to the administrative burden arguments or the concern that vulnerable people might struggle to document their conditions. Right-wing outlets also did not extensively cover the criticism from Democratic governors who called for implementation delays or the legal risks identified by CBPP.
Deep Dive
The specific angle of this story centers on how CMS restricted the medical frailty exemption definition beyond what states expected and what advocates say the law permits. States had anticipated CMS would mirror an existing medical frailty definition used for alternative benefit plans and allow state flexibility to go beyond that definition, but instead the rule tied medical frailty specifically to the ability to comply with the community engagement requirement and prohibited states from expanding the definition. This narrowing is the story's core—not the work requirements themselves, which were established by law last year, but how CMS operationalized one critical exemption. What each side gets right and omits: Progressives correctly identify that the rule departs from CMS's prior informal guidance and adds a functional impairment test the statute does not explicitly require. CMS had reportedly told states they could define medical frailty within H.R. 1's parameters, which include blindness, disability, substance use disorder, disabling mental disorder, physical/intellectual/developmental disability, and serious or complex medical condition. Conservative supporters of the rule are correct that diagnosis alone does not necessarily indicate inability to work—a cancer patient may work part-time, or someone with HIV on medication may have full work capacity. However, progressives argue the rule shifts burden to individuals to prove functional impairment, while the statute lists the conditions themselves as qualifying. Conservatives largely avoid engaging with the legal vulnerability argument CBPP raises, instead framing the rule as common-sense fraud prevention. What to watch: The most significant pending question is whether litigation will succeed. Comments on the interim final rule are due July 31, 2026. If groups challenge the rule and courts agree it exceeds CMS's statutory authority, the agency would face pressure to revise before or after January 2027 implementation. Additionally, six Democratic governors already called for a delay of the requirements if the final rules differed from their assumptions. Second, the practical implementation challenge remains acute: states will have to significantly re-work policy and systems and may not be able to automatically identify individuals who qualify for the exemption when systems go live, requiring much more manual work over the long term. Third, coverage loss projections will become clearer when states begin enrollment in January 2027; the gap between CMS's estimate (7% of those meeting the requirement or qualifying for an exemption will nonetheless lose coverage due to administrative or procedural issues) and outside projections like the Urban Institute's will shape political momentum.